These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20885070)

  • 41. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort].
    Chotkowska E; Jasiński B; Kupść W; Broda G
    Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method.
    Nakamura M; Yokoyama S; Kayamori Y; Iso H; Kitamura A; Okamura T; Kiyama M; Noda H; Nishimura K; Nakai M; Koyama I; Dasti M; Vesper HW; Teramoto T; Miyamoto Y
    Clin Chim Acta; 2015 Jan; 439():185-90. PubMed ID: 25444739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
    Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases.
    Nakajima K; Nakajima Y; Takeichi S; Fujita MQ
    Atherosclerosis; 2008 May; 198(1):237-46. PubMed ID: 17977545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population.
    Yokokawa H; Yasumura S; Tanno K; Ohsawa M; Onoda T; Itai K; Sakata K; Kawamura K; Tanaka F; Yoshida Y; Nakamura M; Terayama Y; Ogawa A; Okayama A
    J Atheroscler Thromb; 2011; 18(2):89-98. PubMed ID: 20972352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database.
    Jameson K; Zhang Q; Zhao C; Ramey DR; Tershakovec AM; Gutkin SW; Marrett E
    Curr Med Res Opin; 2014 Apr; 30(4):655-65. PubMed ID: 24495126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol.
    Larsson A; Hagström E; Nilsson L; Svensson MK
    Ups J Med Sci; 2018 Jun; 123(2):94-99. PubMed ID: 29745278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults.
    Yu HH; Ginsburg GS; Harris N; Rifai N
    Am J Cardiol; 1997 Nov; 80(10):1295-9. PubMed ID: 9388101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for dyslipidemia. Practice parameter.
    Hostetter AL
    Am J Clin Pathol; 1995 Apr; 103(4):380-5. PubMed ID: 7726130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of the Friedewald formula for the estimation of low density lipoprotein cholesterol in a sub-Saharan African population.
    Choukem SP; Manases T; Nda-Mefoo JP; Dimala CA; Mboue-Djieka Y; Sobngwi E; Kengne AP
    Clin Biochem; 2018 Mar; 53():25-30. PubMed ID: 29273329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.
    Du Y; Sun H; Li Y; Shi X; Pei D; Qi D; Wang B
    Clin Lab; 2014; 60(8):1295-300. PubMed ID: 25185414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calculated low-density lipoprotein cholesterol remains a viable and important test for screening and targeting therapy.
    Abudu N; Levinson SS
    Clin Chem Lab Med; 2007; 45(10):1319-25. PubMed ID: 17727314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Appropriate Level of Low-Density Lipoprotein Cholesterol for Secondary Prevention of Coronary Artery Disease.
    Naito R; Miyauchi K; Konishi H; Tsuboi S; Ogita M; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
    J Atheroscler Thromb; 2016; 23(4):413-21. PubMed ID: 26558399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reference values of serum lipid].
    Seishima M; Niwa T; Maeda S
    Rinsho Byori; 2001 Nov; 49(11):1115-21. PubMed ID: 11769557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B).
    Elshazly MB; Quispe R; Michos ED; Sniderman AD; Toth PP; Banach M; Kulkarni KR; Coresh J; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2015 Aug; 132(8):667-76. PubMed ID: 26137953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selection, validation, standardization, and performance of a designated comparison method for HDL-cholesterol for use in the cholesterol reference method laboratory network.
    Kimberly MM; Leary ET; Cole TG; Waymack PP
    Clin Chem; 1999 Oct; 45(10):1803-12. PubMed ID: 10508128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study.
    Bao W; Srinivasan SR; Wattigney WA; Bao W; Berenson GS
    Arch Intern Med; 1996 Jun; 156(12):1315-20. PubMed ID: 8651840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.